 Takeda Pharmaceutical Company Limited NYSE: TAK announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a T cell startup. A little more than four years ago, Takeda stepped in to help bankroll GammaDelta Therapeutics with a 100 million injection. 